fludarabine and plitidepsin

fludarabine has been researched along with plitidepsin in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Bezares, RF; Bitsmans, A; Borge, M; Galmarini, CM; Gamberale, R; Giordano, M; González, M; Jancic, C; Morande, PE; Nannini, P; Rodríguez, AL; Zanetti, SR	1

Other Studies

1 other study(ies) available for fludarabine and plitidepsin

Article	Year
The cytotoxic activity of Aplidin in chronic lymphocytic leukemia (CLL) is mediated by a direct effect on leukemic cells and an indirect effect on monocyte-derived cells. Investigational new drugs, 2012, Volume: 30, Issue:5 Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Caspase 3; Cell Death; Cell Survival; Cyclophosphamide; Depsipeptides; Drug Resistance, Neoplasm; Drug Synergism; Female; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Leukocytes, Mononuclear; Male; Middle Aged; Monocytes; Peptides, Cyclic; Poly(ADP-ribose) Polymerases; Reactive Oxygen Species; Vidarabine	2012

Article

Year

The cytotoxic activity of Aplidin in chronic lymphocytic leukemia (CLL) is mediated by a direct effect on leukemic cells and an indirect effect on monocyte-derived cells.

Investigational new drugs, 2012, Volume: 30, Issue:5

Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Caspase 3; Cell Death; Cell Survival; Cyclophosphamide; Depsipeptides; Drug Resistance, Neoplasm; Drug Synergism; Female; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Leukocytes, Mononuclear; Male; Middle Aged; Monocytes; Peptides, Cyclic; Poly(ADP-ribose) Polymerases; Reactive Oxygen Species; Vidarabine

2012